The aim is to address concerns about the reproducibility and methodological rigor in the study of senolytic activity.
Critically review the methodologies used in the original study.
Evaluate the evidence supporting the claims of senolytic activity.
Suggest improvements for future studies in this field.
Identified gaps in methodology impacting reproducibility.
Highlighted the need for clearer experimental protocols.
Encouraged more detailed reporting of results and analysis.
Abstract
Comment on “Reevaluating the Senolytic Activity of a GLS1 Inhibitor and an Anti-PD-1 Antibody: Toward Greater Reproducibility and Methodological Rigor” by Kawamoto et al.